Angela Buonadonna - Concepedia

Author

Angela Buonadonna

Also Known As

A BUONADONNA, A Buonadonna, A L Buonadonna, A. Buonadonna, A. L. Buonadonna, A.L. Buonadonna, Andrea, Mario D’, Angela Buonadonna, C Belluco, J M Broto

294

Publications

13.4K

Citations

H-Index

Concepts

All Affiliations

Centro di Riferimento Oncologico Istituti di Ricovero e Cura a Carattere Scientifico Istituto Oncologico Veneto Fondazione IRCCS Istituto Nazionale dei Tumori Azienda Ospedaliera Universitaria Pisana

About

Angela Buonadonna is an author at Centro di Riferimento Oncologico specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	48	5.3K
2	Health Sciences	11	11	593
3	Nursing	2	2	352
4	Engineering	1	1	58
5	Public Health	1	1	37

Angela Buonadonna

108

Publications

12K

Citations

H-Index

Page 1

	Year	Citations
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	1.6K
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer Fotios Loupakis, Chiara Cremolini, Gianluca Masi, New England Journal of Medicine	2014	1.1K
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, Annals of Oncology Surgical OncologySoft Tissue SurgeryVisceral SarcomasSurgical PathologyHistopathology	2021	879
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	747
Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial S. Frustaci, F. Gherlinzoni, Antonino De Paoli, Journal of Clinical Oncology	2001	702
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, Stefan Bielack, N. Abecassis, Annals of Oncology	2018	618
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, Jean‐Yves Blay, N. Abecassis, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineSurgical PathologyGastroenterology	2021	509
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson, The Lancet Drug SafetyAdverse Drug ReactionsPharmacoepidemiologyPharmacologyPharmacogenomics	2023	462
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up Sandra J. Strauss, Anna Maria Frezza, N. Abecassis, Annals of Oncology Bone DiseaseBone SarcomasSurgical OncologyBone ImagingMedicine	2021	408
The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer Giuseppe Toffoli, Erika Cecchin, Giuseppe Corona, Journal of Clinical Oncology	2006	333

Page 1